Cargando…
5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis
[Image: see text] Previous studies have indicated that the pathogenesis of amyotrophic lateral sclerosis (ALS) is closely linked to 5-hydroxytryptamine (5-HT). To investigate this further, we administered 5-HT receptor antagonists to SOD1*G93A transgenic (ALS mouse model) and wide-type mice. This in...
Autores principales: | Jiang, Shi-Shi, Gong, Meng-Ni, Rao, Wei, Chai, Wen, Chen, Wen-Zhi, Zhang, Xiong, Nie, Hong-Bing, Xu, Ren-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233787/ https://www.ncbi.nlm.nih.gov/pubmed/36926731 http://dx.doi.org/10.4103/1673-5374.367929 |
Ejemplares similares
-
A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G
por: Yang, Fang, et al.
Publicado: (2022) -
Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis
por: Xu, Ren-Shi, et al.
Publicado: (2021) -
Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019) -
Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
por: Amin, Azin, et al.
Publicado: (2020) -
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2011)